Integrated DNA Technologies

Our vision of enabling researchers to rapidly move from the lab to life-changing advances reflects our commitment to a healthier, brighter future for all. 🧬

[Integrated DNA Technologies @idtdna]

Boost your edits and fast-track your breakthrough. 🚀
Learn how our Alt-R™ HDR Enhancer Protein improves CRISPR knock-in efficiency by promoting HDR pathway precision—seamlessly integrated into workflows.

Full video here: https://t.co/fKAxOx1GF3
Discover what’s possible here: https://t.co/Ig4Fbb2R46

#CRISPR #CRISPRknockin

[Integrated DNA Technologies @idtdna]

IDT LOVES SUPPORTING @iGEM! We offer up to 40kb of gBlocks™ Gene Fragments or equivalent value of IDT products—but only to registered teams! Make sure you register with us by September 21. Learn more here: https://t.co/aM3bxOR190

[Integrated DNA Technologies @idtdna]

#ESHG is in full swing, and we’re having a blast! 🙌 Remember to stop by booth #622—our trusted experts are ready to discuss how our #NGSsolutions can support your research, from amplification to hybrid capture and automation-friendly library prep. See you soon! 👋

[Integrated DNA Technologies @idtdna]

MCED and MRD research are redefining what’s possible in #cancerresearch. The challenge? Identifying one fragment of tumor DNA among millions—and doing it with consistency, at scale, in research workflows.

That’s where IDT supports researchers. For nearly 20 years, we’ve supported MRD and MCED assay innovations—delivering tools designed for low-input workflows, sample-to-sequencing efficiency, and scalability across research pipelines.

This is scientific progress in motion.

Read more from IDT's Steven Henck and Scott McCuine about what it will take to make MCED and MRD a reality: https://t.co/WpzagrBBXi

[Integrated DNA Technologies @idtdna]

As #clinicalNGS continues its rapid expansion, labs face increasing pressure to balance innovation with compliance. Regulatory alignment isn’t just a requirement—it’s a strategic foundation for growth. Ashleigh Dawley, director of global RA at IDT, explores how labs can build scalable, audit-ready workflows—from validating #bioinformatics platforms to selecting the right reagents and partners. Read more in @todaysclinical here: https://t.co/FelHdllZkO

[Association for Molecular Pathology @AMPath]

Register now for a FREE online corporate workshop June 25 by @idtdna:

“Comprehensive DNA and RNA Profiling in Hematolymphoid Malignancies: Enabling Research Focused CGP Approaches with Archer™ FUSIONPlex® and VARIANTPlex® Assays.”

https://t.co/jHCl1jIFxh

[Integrated DNA Technologies @idtdna]

📣New, free application note!📣
We collaborated with @MissionBio to highlight how Nechama Kalter & the Ayal Hendel lab are characterizing CRISPR edits in primary T cells. See how they paired our rhAmpSeq™ with the Tapestri® platform to create a two-tiered workflow that concurrently measures zygosity, structural variations, and surface proteins to fully resolve multiplex editing activity.

🔗Download it here: https://t.co/GQHsvBa0Ni

[Integrated DNA Technologies @idtdna]

We’re a week away from #ESHG2026! 🙌 Join IDT trusted experts at booth #622 to explore how our #NGS solutions can support reproducible, scalable, and automation‑ready workflows across your research. From amplification to hybrid capture and automation‑friendly library prep, discover how we can help your lab to move from discovery to insight. Learn more here: https://t.co/pvhpBLPQUG

[Integrated DNA Technologies @idtdna]

As #CRISPR programs move closer to the clinic, confidence in gene editing safety becomes just as critical as editing efficiency. Our CRISPR Off-target Analysis Services are designed to help you identify, prioritize, and confirm off-target edits early—so you can advance your program with clarity and confidence: https://t.co/jRa7qHe7Xg

[Illumina @illumina]

We’re working with @idtdna (IDT) to make oncology insights more accessible and actionable.

By enabling IDT's custom panels with DRAGEN's oncology pipeline, we’re delivering an integrated, end-to-end solution for somatic oncology research that streamlines analysis and reduces hands-on processing steps. DRAGEN Somatic for IDT Custom Panels features a new, low-quality FFPE mode to analyze challenging samples and ensures that researchers can collect more reliable insights from degraded oncology research samples. #genomics #multiomics

[Integrated DNA Technologies @idtdna]

We’re proud to unveil our latest partnership with @Illumina! 🤝 This collaboration will enable an integrated, end-to-end solution for somatic #oncologyresearch by combining Illumina’s DRAGEN™ secondary analysis with IDT’s xGen™ FFPE and cfDNA workflows.

Read more: https://t.co/p7qP8GzKWT

#NGS #cancerresearch #nextgenerationsequencing

[Genetic Engineering & Biotechnology News @GENbio]

Gene Editing at Scale: Clinic Seeks Generalizable Therapies

End-to-end pipelines and regulatory advances aim to expand #geneediting to broad patient populations

@idtdna, @DanaherCorp, @elevatebio, @MassGeneralNews, @AuroraTher, and @MaxCyte_info
#CRISPR
https://t.co/GMhvEOXyXa

[Cost Action GenE-Humdi @GeneHumdi]

Jennifer Stott @idtdna opened the second session presenting: "From Target Discovery to Treatment: How IDT is Enabling CRISPR Medicine" showcasing a thorough toolkit to help #GenomeEditing

[Integrated DNA Technologies @idtdna]

In recognition of National Cancer Research Month, we’re highlighting how minimal residual disease (#MRD) assessment and multi-cancer early detection (#MCED) are transforming #cancercare strategies. Learn more about how IDT’s advanced #NGS solutions are powering the research behind this progress: https://t.co/ywPmBTlKCS

#cancerresearch #oncologyresearch #cancercare #NCRM #cancerresearchmonth

[Integrated DNA Technologies @idtdna]

ICYMI: The revolutionary potential of CRISPR-Cas gene editing is undeniable, but moving from the design to delivery requires navigating a complex landscape of off-target assessments. New FDA guidance reinforces what #CRISPR pioneers already know: off‑target analysis is essential for clinical success.

🔗 Read more in our latest blog by Morgan Sturgeon, CRISPR applications development manager: https://t.co/CPBeWY7fiS

#offtargetassessment #CRISPRgeneediting

[Integrated DNA Technologies @idtdna]

We’re partnering with @AnsaBio to provide customers with access to long, #complexDNA, ranging from 100 bp to 50 kb! Take a look at how this collaboration has delivered value to Manos Papadakis, senior research scientist, strain development, @dsmfirmenich. 👇

Learn more here: https://t.co/UO0Hxh4R5q

[Integrated DNA Technologies @idtdna]

Boost your edits and fast-track your breakthrough. 🚀
Learn how our Alt-R™ HDR Enhancer Protein improves CRISPR knock-in efficiency by promoting HDR pathway precision—seamlessly integrated into workflows.

Full video here: https://t.co/07hpFXM7wk
Discover what’s possible here: https://t.co/rzWx3nAReC

#CRISPR #CRISPRknockin

[Integrated DNA Technologies @idtdna]

🧬💥REGISTRATION FOR @iGEM IS NOW OPEN!💥🧬 This year, we’re offering DOUBLE the amount of gBlocks™ Gene Fragments—up to 40kb, or equivalent value of IDT products! Last day to register is September 21. We’re so excited to see you all again this year! Learn more: https://t.co/rklycikc76

#iGEM26 #iGEM

[Integrated DNA Technologies @idtdna]

Our new #CRISPRlibraries design tool enables fast, customizable gRNA library creation, allowing you to design and order tailored knockout libraries within minutes. For transcript level perturbation, our enhanced antisense oligonucleotide (ASO) plate ordering platform simplifies the setup of high throughput ASO libraries, supporting efficient and scalable knockdown screening.

🔗Start designing: https://t.co/R7xvY3AoQ7
🔗Order ASOs: https://t.co/BP6hpSZ1Ni

[Integrated DNA Technologies @idtdna]

It's a busy week in Boston.💥
We’ve made it to #TIDES2026! Meet our trusted experts at booth #907 to discover how we can support your research with our CRISPR end-to-end solutions.